Fol. Biol. 2010, 56, 201-205
https://doi.org/10.14712/fb2010056050201
The Effect of a Histone Deacetylase Inhibitor – Valproic Acid – on Nucleoli in Human Leukaemic Myeloblasts
References
1. , R. A., Michaelis, M., Driever, P. H., Cinatl, J. (2005) Evolving anticancer drug valproic acid: insight into mechanism of clinical studies. Med. Res. Rev. 25, 383-393.
<https://doi.org/10.1002/med.20027>
2. , F. M., van Konigsbruggen, S., Navascués, J. A. I. (2007) The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol. 8, 574-585.
<https://doi.org/10.1038/nrm2184>
3. Busch, H., Smetana, K. (1970) The Nucleolus. Academic Press, New York.
4. , A., Candelaria, M., Perez –Plascencia, C., Perez-Cardenas, E., de la Cruz-Hernandez, E., Herrera, L. A. (2008) Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat. Rev. 34, 206-222.
<https://doi.org/10.1016/j.ctrv.2007.11.003>
5. , J. H., Eichner, D. (1958) Quantitative ribonukleinsäure-untersuchungen an den ganglienzellen des nucleus supraopticus der Albino-ratte under experimentellen bedigungen (kochsaltz-belastung). Z. Zellforsch. Mikrosk. Anat. 48, 187-200.
<https://doi.org/10.1007/BF00319276>
6. , S., Lauricella, M., Tesoriere, G. (2008) Histone deacetylase inhibitors: apoptotic effects and clinical implications. Int. J. Oncol. 33, 637-646.
7. , G., Fulcrant, G., Magnaghi-Jaulin, L., Jaulin, C. (2009) Histone deacetylase inhibitors and genomic instability. Cancer Lett. 274, 169-176.
<https://doi.org/10.1016/j.canlet.2008.06.005>
8. , S., Puvion, E. (1980) The ultrastructural visualization of nucleolar and extranucleolar RNA synhesis and distribution. Int. Rev. Cytol. 65, 255-299.
<https://doi.org/10.1016/S0074-7696(08)61962-2>
9. , D. M., Chen, X. O., Liang, R., Dong, B. X., Yin, W. (2006) Inhibition of proliferation and induction of apoptosis and differentiation of leukemic cell line by sodium valproate. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14, 21-24.
10. , P. (1995) Catching RNA polymerase I in flagranti: ribosomal genes are transcribed in the dense fibrillar component of the nucleolus. Exp. Cell Res. 216, 285-289.
<https://doi.org/10.1006/excr.1995.1036>
11. , J., Hrabeta, J., Eckschager, T. (2010) Valproic acid in the complex therapy of maligant tumors. Curr. Drug Targets 11, 361-379.
<https://doi.org/10.2174/138945010790711923>
12. , M. O., Dundr, M., Szebeni, A. (2000) The nucleolus: an old factory with unexpected capabilities. Trends Cell Biol. 10, 189-196.
<https://doi.org/10.1016/S0962-8924(00)01738-4>
13. T. (1998) The plurifunctional nucleolus. Nucleic Acids Res. 26, 3871-3876.
<https://doi.org/10.1093/nar/26.17.3871>
14. , R L. (1998) Methods used to study structure and function of the nucleolus. Methods Cell Biol. 53, 303-301.
<https://doi.org/10.1016/S0091-679X(08)60884-5>
15. , A., Ferreri, A. M., Rocchi, P., Guerra, F., Orlandi, M. (2010) Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells. Anticancer Res. 30, 535-540.
16. , I., Shaw, P. J., Cmarko, D. (2006) New insights into nucleolar architecture and activity. Int. Rev. Cytol. 255, 177-235.
<https://doi.org/10.1016/S0074-7696(06)55004-1>
17. , V., Gozzini, A., Ferrari, G. (2007) Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr. Drug Metab. 8, 383-393.
<https://doi.org/10.2174/138920007780655397>
18. , H. G., Wachtler, F. (1993) The nucleolus. Anat. Embryol. 188, 513-536.
<https://doi.org/10.1007/BF00187008>
19. , K., Lejnar, J., Potměšil, M. (1969) A further contribution to the demonstration of RNA and nucleoli of blood cells in smear preparations. Folia Haematol. 91, 381-384.
20. K. (2002) Structural features in blood, leukemic, lymphoma and myeloma cells. Eur. J. Histochem. 46, 125-132.
<https://doi.org/10.4081/1661>
21. Smetana, K. (2005) Nucleoli in blood cells of hematologic malignancies (Structure, cytochemistry of nucleoli in leukemic, lymphoma and myeloma cells). In: Trends in Leukaemia Research, Romero, R. M. ed. Nova Science Publishers, Hauppage, New York, pp. 155-179.
22. , K., Klamová, H., Mikulenková, D., Pluskalová, M., Hrkal Z. (2006) On the nucleolar size and density in human early granulocytic progenitors, myeloblasts. Eur. J. Histochem. 50, 119-124.
23. , K., Zápotocký, M., Starková, J., Trka, J. (2007) Effect of histone deacetylase inhibitors on the cell nucleus and nucleolus of leukemic myeloblasts in vitro – a cytochemical study. Acta Histochem. 109, 413-419.
<https://doi.org/10.1016/j.acthis.2007.04.003>
24. , K., Zápotocký, M., Starková, J., Trka, J. (2008a) To the nucleolar density and size in apoptotic human leukemic myeloblasts produced in vitro by Trichostatin A. Eur. J. Histochem. 52, 143-148.
<https://doi.org/10.4081/1204>
25. , K., Jirásková, I., Otevřelová, P., Kalousek, I. (2008b) The RNA content of nucleolar bodies is related to their size – a cytochemical study on human monocytes and lymphocytes in blood smears and blood cytospins. Folia Biol. (Praha) 54, 130-133.
<https://doi.org/10.14712/fb2008054040130>
26. , J., Cang, S., Ma, Y., Liu, D. (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J. Hematol. Oncol. 3, 5.
<https://doi.org/10.1186/1756-8722-3-5>
27. , H., Hurt, E. (2003) Pre-ribosomes on the road from the nucleolus to the cytoplasm. Trends Cell Biol. 13, 255-263.
<https://doi.org/10.1016/S0962-8924(03)00054-0>
28. , F., Stahl, A. (1993) The nucleolus: structural and functional interpretation. Micron 24, 473-505.
<https://doi.org/10.1016/0968-4328(93)90026-W>
